AMERICAN REGENT, INC.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 1967-01-01
- Employees
- 501
- Market Cap
- -
Clinical Trials
64
Active:6
Completed:46
Trial Phases
5 Phases
Phase 1:8
Phase 2:15
Phase 3:25
+2 more phases
Drug Approvals
44
FDA:44
Drug Approvals
- Prev
- 1
- 2
- 3
- 4
- 5
- Next
Clinical Trials
Distribution across different clinical trial phases (59 trials with phase data)• Click on a phase to view related trials
Phase 3
25 (42.4%)Phase 2
15 (25.4%)Phase 1
8 (13.6%)Phase 4
7 (11.9%)Not Applicable
4 (6.8%)Safety and Tolerability of 200mg and 100mg of Venofer Administered to Hemodialysis(HD) Patients
- First Posted Date
- 2024-11-15
- Last Posted Date
- 2024-11-15
- Lead Sponsor
- American Regent, Inc.
- Target Recruit Count
- 400
- Registration Number
- NCT06690450
Tralement vs. Fixed-dose Trace Element Combination Product in Patients >3 to 17 Years of Age Requiring Long-term PN
Phase 4
Withdrawn
- Conditions
- Manganese Safety in Pediatric Patients
- Interventions
- Drug: Fixed-dose trace element combination product of zinc, copper, and selenious acid
- First Posted Date
- 2023-01-10
- Last Posted Date
- 2024-11-15
- Lead Sponsor
- American Regent, Inc.
- Target Recruit Count
- 80
- Registration Number
- NCT05677126
Tralement Versus a Fixed-dose Trace Element Combination Product to Evaluate Manganese Safety
Phase 4
Withdrawn
- Conditions
- Manganese Safety in Adults
- Interventions
- Drug: Fixed-dose trace element combination product of zinc, copper, and selenious acid
- First Posted Date
- 2022-12-22
- Last Posted Date
- 2025-02-12
- Lead Sponsor
- American Regent, Inc.
- Target Recruit Count
- 108
- Registration Number
- NCT05661682
Safety, Tolerability, PK and PD of Intravenous Ferric Carboxymaltose in Infants With Iron Deficiency Anemia
- First Posted Date
- 2021-07-20
- Last Posted Date
- 2023-01-06
- Lead Sponsor
- American Regent, Inc.
- Registration Number
- NCT04968379
- Locations
- 🇺🇸
University of Iowa, Iowa City, Iowa, United States
🇺🇸Cohen Children's Medical Center, New Hyde Park, New York, United States
🇺🇸Nationwide Children's Hospital, Columbus, Ohio, United States
Efficacy and Safety of Intravenous Ferric Carboxymaltose in Pediatric Patients With Iron Deficiency Anemia and Unsatisfactory Response Oral Iron Under Study Protocol 1VIT17044
- First Posted Date
- 2020-02-17
- Last Posted Date
- 2022-03-21
- Lead Sponsor
- American Regent, Inc.
- Target Recruit Count
- 7
- Registration Number
- NCT04269707
- Locations
- 🇺🇸
South Florida Research Phase I-IV, Miami Springs, Florida, United States
🇺🇸Miami Clinical Research, Miami, Florida, United States
- Prev
- 1
- 2
- 3
- 4
- 5
- 11
- Next
News
No news found